Glimsentro-PG1 Tablet SR
By Glimsentro-PG
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Sentro Pharma & Healthcare
G-1/A, Star Hub Building, Sahar Airport Road, Andheri East, Mumbai-400099

Expires on or after
September, 2025

liver
Glimsentro-PG1 Tablet SR should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Glimsentro-PG1 Tablet SR in such patients, therefore it's important to consult your doctor. The use of Glimsentro-PG1 Tablet SR is not advised for individuals with severe liver disease. Please be cautious and seek medical advice if you have any liver concerns before using this medication.

kidney
Glimsentro-PG1 Tablet SR should be used cautiously by patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Monitor kidney function regularly while on this medication. Consult your doctor.

alcohol
It is not safe to drink alcohol while taking Glimsentro-PG1 Tablet SR.

driving
When your blood sugar is too low or too high, it can affect your ability to drive safely. If you experience these symptoms, avoid driving while taking Glimsentro-PG1 Tablet SR.

pregnancy
Glimsentro-PG1 Tablet SR may be unsafe during pregnancy. Animal studies suggest harm to the developing baby. Consult your doctor for a careful assessment of benefits and risks.

breastfeeding
Glimsentro-PG1 Tablet SR is likely unsafe to use while breastfeeding. Limited data indicates it can pass into breast milk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹148.88
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024